Shanghai Junshi Biosciences Co., Ltd. (SHA:688180)
China
· Delayed Price · Currency is CNY 30.13
-0.51 (-1.66%)
May 22, 2025, 2:45 PM CST
SHA:688180 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -1,233 | -1,281 | -2,283 | -2,388 | -720.91 | -1,669 | Upgrade
|
| Depreciation & Amortization | 298.65 | 298.65 | 315.4 | 282.54 | 248.98 | 146 | Upgrade
|
| Other Amortization | 28.42 | 28.42 | 17.12 | 13.1 | 15.93 | 8.34 | Upgrade
|
| Loss (Gain) From Sale of Assets | -12.78 | -12.78 | -29.41 | -22.57 | -0.81 | -1.86 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.94 | 0.94 | 0.52 | 0.19 | 0.03 | -45.31 | Upgrade
|
| Loss (Gain) From Sale of Investments | 71.23 | 71.23 | 75.19 | 51.21 | -65.75 | 5.62 | Upgrade
|
| Provision & Write-off of Bad Debts | -14.67 | -14.67 | 18.34 | -0 | 0.36 | -0.34 | Upgrade
|
| Other Operating Activities | 294.07 | -10.02 | -178.56 | -250.42 | 7.55 | 37.77 | Upgrade
|
| Change in Accounts Receivable | 54.21 | 54.21 | -314.42 | 1,230 | -770.56 | -482.17 | Upgrade
|
| Change in Inventory | -159.27 | -159.27 | -32.45 | -136.39 | -154.82 | -166.99 | Upgrade
|
| Change in Accounts Payable | -415.29 | -415.29 | 262.67 | -505.73 | 702.33 | 685.97 | Upgrade
|
| Change in Other Net Operating Assets | -10.67 | -10.67 | 19.01 | 90.04 | 195.05 | 30.73 | Upgrade
|
| Operating Cash Flow | -1,082 | -1,434 | -2,005 | -1,776 | -605.05 | -1,456 | Upgrade
|
| Capital Expenditures | -639.9 | -690.99 | -832.57 | -393.95 | -901.77 | -580.47 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.87 | 1.87 | 4.1 | 0 | 0.01 | - | Upgrade
|
| Cash Acquisitions | - | - | - | 2.22 | - | - | Upgrade
|
| Investment in Securities | -540.63 | -247.76 | -207.9 | -104.24 | -1,045 | -172.13 | Upgrade
|
| Other Investing Activities | 17.52 | 44.1 | 103.19 | 58.76 | 28.95 | 12.19 | Upgrade
|
| Investing Cash Flow | -1,161 | -892.78 | -933.19 | -437.21 | -1,918 | -740.41 | Upgrade
|
| Long-Term Debt Issued | - | 2,307 | 977.1 | 840.36 | 500 | 374.24 | Upgrade
|
| Long-Term Debt Repaid | - | -1,214 | -533.78 | -160.65 | -828.36 | -426.76 | Upgrade
|
| Net Debt Issued (Repaid) | 269.63 | 1,093 | 443.32 | 679.71 | -328.36 | -52.52 | Upgrade
|
| Issuance of Common Stock | - | - | 152.59 | 3,795 | 2,122 | 4,527 | Upgrade
|
| Repurchase of Common Stock | -4 | -4 | -26.89 | - | - | - | Upgrade
|
| Common Dividends Paid | -83.16 | -73.79 | -38.23 | -19.16 | -16.69 | -43.16 | Upgrade
|
| Other Financing Activities | 7.61 | 7.81 | 181.03 | 157.81 | 889 | -17.68 | Upgrade
|
| Financing Cash Flow | 190.09 | 1,023 | 711.83 | 4,613 | 2,666 | 4,414 | Upgrade
|
| Foreign Exchange Rate Adjustments | 9.97 | 12.01 | 7.55 | 92.27 | -23.23 | -45.77 | Upgrade
|
| Net Cash Flow | -2,043 | -1,291 | -2,219 | 2,492 | 119.61 | 2,171 | Upgrade
|
| Free Cash Flow | -1,721 | -2,125 | -2,838 | -2,170 | -1,507 | -2,037 | Upgrade
|
| Free Cash Flow Margin | -83.24% | -109.06% | -188.85% | -149.31% | -37.44% | -127.71% | Upgrade
|
| Free Cash Flow Per Share | -1.75 | -2.16 | -2.88 | -2.36 | -1.69 | -2.48 | Upgrade
|
| Cash Income Tax Paid | 56.25 | 78.6 | -65.42 | -261.57 | -43.19 | -25.64 | Upgrade
|
| Levered Free Cash Flow | -261.82 | -1,104 | -2,112 | -1,229 | -1,174 | -1,394 | Upgrade
|
| Unlevered Free Cash Flow | -226.53 | -1,072 | -2,094 | -1,210 | -1,160 | -1,375 | Upgrade
|
| Change in Net Working Capital | -903.81 | -137.73 | 64.96 | -527.02 | 263.06 | -83.95 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.